Physician profile
Robert O'Bryan
NPI 1790051118
$194.82
in general payments reported to CMS, 2019-2025
10 companies · $17.23 in 2025
The $17.23 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.03 · 2023: $106 · 2024: $42.73 · 2025: $17.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $31.81 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $23.42 | 2023 | |
| Abbott Laboratories | $23.08 | 2024 | Octrode |
| Amgen INC. | $19.65 | 2024 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $17.58 | 2023 | Vaxneuvance, Proquad, Gardasil 9 |
| Cipher Pharmaceuticals US LLC | $17.23 | 2025 | Spinosad, Natroba |
| Glaxosmithkline, LLC. | $16.57 | 2023 | Trelegy Ellipta |
| Lilly USA, LLC | $16.45 | 2023 | Mounjaro |
| Hologic Sales and Service, LLC | $14.72 | 2022 | |
| Novo Nordisk INC | $14.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert O'Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.